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Abstract: 
The internal consistency, validity, and factor structure of the Shacham shortened version (37 
items) of the 65-item profile of mood states (POMS) were examined with a sample of 428 cancer 
patients who were awaiting bone marrow transplantation. Cronbach's alphas ranging from 0.78 
to 0.91 were obtained for each of the six subscales of the POMS-short form (POMS-SF) and for 
the total 37-item scale. Correlations with the CES-D, the Self-Rated Karnofsky, the MOS SF-20 
Physical Functioning, and the Bradburn Positive and Negative Affect Scales provided evidence 
of the convergent and discriminant validity of the POMS-SF. Results of a confirmatory factor 
analysis were supportive of the 6-factor interpretation of the POMS items in the 37-item version 
of the POMS. 
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INTRODUCTION 
The profile of mood states (POMS; McNair et al., 1971) was developed to assess transient 
distinct mood states. The original form of the measure consisted of 65 adjectives that were rated 
on a 5- point scale from not at all to extremely. Developed on the basis of a series of factor 
analytic studies (McNair et al., 1971), six factor-based subscales were derived: Tension–Anxiety, 
Depression– Dejection, Anger–Hostility, Fatigue–Inertia, Vigor– Activity, and Confusion–
Bewilderment. A seventh score of Total Mood Disturbance is also calculated by subtracting the 
score on the one positively scored subscale, Vigor–Activity, from the sum of the other five 
subscales. McNair et al. (1992) assert that the Total Mood Disturbance score makes clinical 
sense and can be presumed to be highly reliable because of the intercorrelations among the six 
primary POMS factors. 
A number of studies have reported on use of the POMS to assess psychological aspects of cancer 
(Weisman and Worden, 1976; Sobel and Worden, 1979; McCorkle and Quint-Benoliel, 1983; 
Silberfarb et al., 1983; Shacham, 1983; Cassileth et al., 1985; Cella et al., 1989). As 
multidimensional approaches to the measurement of treatment outcomes and assessment of 
quality of life of cancer patients have grown in popularity, the use of the POMS to measure the 
mood disturbance or psychological distress associated with cancer treatment has increased. 
There is considerable pressure on those who would like to include a self-report measure of affect 
or mood as a psychological outcome measure in assessing the effects of treatment to use as brief 
a scale as possible, in order to reduce respondent burden, as long as it is appropriate for the 
population being studied and has adequate reliability and validity. The 65-item POMS presents 
two problems for researchers who want to use it in the measurement of distress in the evaluation 
of quality of life in cancer patients: (a) its length and (b) the fact that its norms are based on 
college students and outpatient psychiatric patients (McNair et al., 1971). While the 65-item 
POMS takes only about 5–7 min for healthy individuals to complete, according to the POMS test 
manual, patients who are physically ill may require three times as long to complete the 
instrument, and some patients will have difficulty in completing the test at all (McNair et al., 
1971). In an attempt to deal with these problems, Cella et al. (1987) developed an 11-item form 
of the POMS with a large sample of adult cancer patients, but they did so by giving up the six 
subscales in favor of a single factor scale of Total Mood Disturbance.  
Guadagnoli and Mor (1989) also attempted a revision of the POMS using a sample of cancer 
patients. They were interested in using the POMS to develop a briefer form that would represent 
mood in a less complex format. They revised the POMS item set by removing items ‘reflecting 
somatic content’ and constructed from the remaining items a Negative Affect Scale and a 
Positive Affect Scale.  
Since the 1980s, when these earlier attempts to develop shortened forms of the POMS for use 
with cancer patients were undertaken, quality-of life assessment based on patient self-report has 
become a common approach to the evaluation of cancer treatment outcomes. Quality of life 
(QOL) is generally conceived of as containing both positive and negative dimensions, and the 
POMS has become one of the favored measures to be included in a battery of measures used to 
assess quality of life. It offers the advantage of providing six subscale scores plus a total score of 
disturbance of mood rather than just a global positive–negative index. However, since the POMS 
is usually included in a battery of measures selected to assess other important dimensions of 
QOL, a shorter version developed on the responses of cancer patients that retains its internal 
consistency and still offers the advantage of measuring six mood states that are relevant to 
changes associated with the impact of cancer is highly desirable. 
Shacham (1983) attempted to develop a shorter form of the POMS that retained the six subscales 
based on responses of cancer patients. Shacham administered the 65-item version of the POMS 
to 83 cancer patients who were participating in a study focusing on the effectiveness of pain 
treatments and developed a 37-item form of the scale based on (a) the contribution of items to 
the internal consistency (coefficient alpha) of the scale and (b) the face validity of the items in 
relation to the subscales. It was found that by reducing each of the scales by 2–7 items, internal 
consistency could be maintained and even improved in two subscales (Confusion and Tension), 
while cutting the time for completing the scale in half. The validity of this 37-item scale was 
examined by correlating the shortened scales with the original ones; all correlations were above 
0.95. No factor analysis was reported, probably because of the relatively small sample of 
patients. 
Curran et al. (1995) examined the internal consistency and correlation of Shacham’s shortened 
subscales with the original 65-item POMS with a number of patient groups (including 341 cancer 
patients) and healthy individuals. They found that for all groups, the internal consistency 
estimates for the POMS-SF subscales were very comparable to those for the original 65-item 
POMS, and correlations between Total Mood Disturbance and subscale scores on the POMS-SF 
and the corresponding scores from the original POMS were all greater than 0.95. However, they 
did not conduct a factor analysis or present validity data. 
This paper goes beyond the Curran et al. evaluation of the Shacham shortened version of the 
POMS by examining the six-subscale structure through a confirmatory factor analysis of a 
sufficiently larger sample of cancer patients. Neither Shacham nor Curran et al. examined the 
validity of this short form of the POMS. Therefore, the convergent and discriminant validity of 
the POMS subscales will also be examined in relation to several other measures of psychological 
distress and patient functioning. 
Regarding convergent validity, it would be expected that the Depression subscale of the POMS 
should correlate the highest of the POMS subscales with the CES-D, which is a measure of 
depressive symptoms. The Fatigue and Vigor POMS subscales would be expected to have the 
highest correlation with the two measures of physical functioning, the MOS Physical 
Functioning Scale and the Self-Rated Karnofsky, which share a focus on somatic dimensions. 
The correlation with fatigue, of course, should be negative. The BNAS should correlate 
positively with the Total Mood Disturbance score and to a lesser extent with the negative 
subscales. Positive Affect would be predicted to have its highest absolute correlation with the 
Vigor subscale. With regard to discriminant validity, the four subscales (Anger, Confusion, 
Depression, and Tension) that deal with somatic aspects of mood should have lower correlations 
with the MOS Physical Functioning Scale and the Self-Rated Karnofsky Performance Scale. 
METHODS 
Sample 
Four hundred seventy-nine patients awaiting bone marrow transplantation (BMT) who met the 
study’s eligibility criteria were invited to participate; consent and completed study instruments 
were obtained from 437 (91.2%). These 437 patients were administered the 37-item Shacham 
version of the POMS scale along with a number of other quality-of-life measures. In the current 
study, only results for the 428 cancer patients among the 437 consented subjects are reported.  
Fifty-nine percent of the participating cancer patients were male, 90% were White, and 72% 
were currently married or living with a partner. The group had a mean age of 39.6 yr (range 18–
65) and had completed an average of 14.3 yr of education (range 6–25). The majority of patients 
had been diagnosed with either lymphoma (35%), acute myelocytic leukemia (21%), or chronic 
myelocytic leukemia (19%). Other diagnoses included Hodgkin’s disease (9%) and acute 
lymphoblastic leukemia (8%). 
Questionnaire administration 
Informed consent was obtained from patients being evaluated for BMT at The Johns Hopkins 
Oncology Center to participate in a large prospective cohort study of late toxicities following 
transplantation, of which this quality-of-life study was a component. An experienced interviewer 
in a face-to-face contact administered interviews and questionnaires to BMT candidates who 
were awaiting a final decision about whether they were to receive a transplant. These interviews 
were conducted before the BMT candidates entered the hospital. Most interviews were 
conducted in a conference room in a short-term outpatient residence used by the Social Work 
Department of the Oncology Center. A few interviews were conducted in other out-patient 
conference rooms. The measures described here were included in a larger questionnaire battery 
of measures intended to assess baseline psychosocial adjustment and quality of life. The study’s 
procedures were approved by The Joint Committee on Clinical Investigations of The Johns 
Hopkins University, and all patients gave informed consent for the interviews and 
questionnaires. Additional demographic and medical data were obtained at the time of the pre-
BMT evaluation. 
Measures 
In addition to the 37-item form of the POMS, other measures that were administered to the 428 
cancer patients included the following: 
Center for Epidemiologic Studies-depression scale (CES-D): A self-report measure of the 
frequency of depression rated for the past week (Radloff, 1977). It consists of 20 items for which 
the respondents are asked to circle a number on a scale of 1–4, with 1 defined as rarely or none 
of the time (less than one day) and 4 defined as most of the time (5–7 days). A score of 16 or 
higher has been established as indicative of a need for psychiatric evaluation for clinical 
depression. The CES-D was developed initially for use in epidemiological surveys with the 
general population, and its use for screening people for psychiatric symptomatology has been 
well established (Myers and Weissman, 1980; Roberts and Vernon, 1983). It has also found use 
in studies of cancer patients as a measure of depressive symptomatology since it has the 
advantage over other measures of depression of including fewer items asking about physical 
concerns that might be expected to reflect symptoms of cancer or its treatment rather than 
depression (Metzer et al., 1985; Devins et al., 1988; Zonderman et al., 1989; Gritz et al., 1990; 
Roberts et al., 1990; Ward et al., 1992; Stommel et al., 1993). 
Bradburn positive and negative affect scales: A set of 10 self-administered questions (5 for 
negative affect, 5 for positive affect) developed by Bradburn and Caplovitz (1965), Bradburn 
(1969) that asks respondents about their recent affective experiences. Intended to be a single 
measure of psychological well-being, the two 5-item clusters were found to load on orthogonal 
factors and subsequently have been treated as separate scales (Beiser, 1974; Cherlin and Reeder, 
1975). The Bradburn Positive Affect Scale (BPAS) and the BNAS have been shown to be useful 
measures of psychological well-being for chronically ill patients (Baker et al., 1994). 
The MOS SF-20 Physical Functioning Scale: A scale from the Medical Outcomes Study (MOS) 
20-item short form (Aaronson et al., 1987) designed at the RAND Corporation (Santa Monica, 
CA) as a quick (55 min) self-administered questionnaire for use in large-scale patient surveys. 
Responses range from 1 (all of the time) to 6 (none of the time) regarding how much of the time 
during the last month the respondents’ health has limited them in each of six types of activities 
they can do, ranging from vigorous activities such as ‘lifting heavy objects, running, or 
participating in strenuous sports’ to activities of daily living such as ‘eating, dressing, bathing, or 
using the toilet.’ 
The Self-Rated Karnofsky performance scale (SR-KPS): A measure of physical functioning for 
cancer patients developed to provide a self-report version of the classic physician-rated Karnosky 
scale (Wingard et al., 1991). Patients rate themselves by a 10-point increment from 40 (low-level 
functioning requiring help) to 100 (high-level functioning requiring no help). In a survey of 70 
cancer patients after bone marrow transplantation, the SR-KPS was validated against a 
physician’s ratings using the traditional Karnofsky scale, and statistically significant kappas were 
obtained (Wingard et al., 1991). 
The Cronbach’s alphas obtained on these measures in the current study are as follows: CES-
D=0.94, Bradburn Positive Affect=0.74, Bradburn Negative Affect=0.59, and MOS SF- 20 
Physical Function=0.85. The relatively lower alpha for the BNAs has been observed before 
(Baker et al., 1996) for this short 5-item scale, but nevertheless the scale has been shown to be a 
useful measure of the affect dimension of QOL among cancer patients (Coward, 1991).  
Statistical analysis 
The data were analyzed using SPSS1 for WindowsTM (SPSS, Inc., 1993). A confirmatory factor 
analysis (CFA) was performed using AMOS (Arbuckle, 1997). The hypothesized model 
evaluated in the factor analysis was one in which items were assigned to one of six factors that 
represent the six subscales from the 65-item POMS. For example, unhappy was assigned to the 
Depression factor and lively was assigned to the Vigor factor. 
This data on the POMS was collected as part of a larger study to assess changes in QOL and 
psychosocial adaptation of BMT recipients over time, and thus it was not the specific purpose at 
the time to collect measures to test the convergent and discriminant validities of the subscales. 
Nevertheless, it is possible because of the large number of measures collected to examine some 
convergent and discriminant correlations with relevant measures. 
RESULTS 
Table 1 presents a comparison of results of this administration of the Shacham version of the 
POMS with the results obtained from the original development of this 37-item form of the 
POMS. The table presents the internal consistency reliability (alpha) coefficients (Cronbach, 
1951) and mean scores for the six subscales resulting from our study in comparison with the 
results reported by Shacham (1983). The reliabilities are quite similar. The mean scores show 
more difference between the two studies, but this is not unexpected as the patient populations are 
somewhat dissimilar. Shacham did not report a reliability for the entire 37-item scale or a mean 
for the Total Mood Disturbance score. In the present study, a Cronbach’s alpha of 0.91 was 
obtained for the 37-item scale; the mean Total Mood Disturbance score was 49.7 (S.D.=18.8). 
Table 1. Reliability analysis and subscale means for short-form POMS 
POMS scale  No. of items  Baker et al.   Shacham 
Alpha  Mean score  Alpha  Mean score 
Depression  8   0.88  7.04   0.91  9.52 
Vigor   6   0.91  12.78   0.87  7.50 
Confusion  5   0.78  6.25   0.82  4.95 
Tension  6   0.87  10.32   0.80  8.64 
Anger   7   0.88  6.44   0.90  4.55 
Fatigue  5   0.90  6.80   0.87  8.65 
 
Factor loadings from the confirmatory factor analysis are shown in Table 2. Unlike more 
traditional analyses, which are evaluated in terms of a single test statistic (e.g., t-test, chi-square, 
etc.), the fit of a CFA is assessed using multiple indices. AMOS generates a number of 
commonly reported goodness-of-fit statistics by which to evaluate the appropriateness of a 
proposed model. 
The factor loadings for all items on their proposed subscales are highly significant. Although the 
chi-square goodness-of-fit statistic is statistically significant (w2=1697, d.f.=614, p50.001), this 
is not the best criterion by which to determine the adequacy of the model, as it is sensitive to 
sample size and may detect trivial discrepancies in fit with moderate to large samples (Bollen, 
1989). Other indices seem to indicate that the fit of the proposed model, which preserves the six 
POMS subscales, is adequate. The relative chisquare statistic of 2.76, which is in the range of a 
ratio of 2 : 1 or 3 : 1, indicates an acceptable fit (Carmines and McIver, 1981). The root mean 
square residual (RMR) of 0.07 is slightly higher than the preferred 50.05. The adjusted 
goodness-of-fit index (AGFI) of 0.77 and the Bentler comparative fit index (CFI) of 0.88 both 
approach but do not quite meet the level for each, which is indicative of a good fit, 0.8 for AGFI 
(Cole, 1987) and 0.9 for CFI (Bentler and Bonett, 1980). The root mean square error of 
approximation (RMSEA) of 0.06, which is between 0.05 and 0.08, indicates an acceptable fit 
(Browne and Crudeck, 1993). Taken together, these indices indicate that the fit of the proposed 
model to the data is adequate. 
Table 3 shows the intercorrelations of the six subscale scores. The six subscales are highly 
correlated, a finding which is consistent with the original development of the 65-item POMS 
(McNair et al., 1971).  
Table 2. Factor loadings from confirmatory factor analysis 
Subscale/Item  Factor loading 
Depression 
Unhappy   0.71 
Sad    0.73 
Blue   0.81 
Hopeless  0.71 
Discouraged   0.72 
Miserable   0.74 
Helpless   0.66 
Worthless   0.55 
Vigor 
Lively    0.72 
Active   0.74 
Energetic   0.89 
Cheerful   0.68 
Full of pep   0.86 
Vigorous   0.82 
Anger 
Angry    0.75 
Peeved   0.76 
Annoyed   0.71 
Grouchy   0.61 
Resentful   0.73 
Bitter    0.77 
Furious   0.73 
Tension 
Tense    0.82 
On edge   0.81 
Uneasy   0.77 
Restless   0.62 
Nervous   0.77 
Anxious   0.55 
Confusion 
Confused   0.74 
Unable to concentrate 0.63 
Bewildered   0.75 
Forgetful   0.47 
Uncertain   0.64 
Fatigue 
Worn out   0.75 
Fatigued  0.85 
Exhausted   0.89 
Weary    0.71 
Bushed   0.84 
Table 3 is omitted from this formatted document. 
Table 4 presents the correlations of the shortform POMS subscales and Total Mood Disturbance 
scores with other psychosocial measures administered to the study participants. The BNAS alpha 
is somewhat low, but not inconsistent with the range from 0.48 to 0.73 previously reported in the 
literature (Cherlin and Reeder, 1975; Warr, 1978). Both convergent and discriminant validity are 
shown by the patterns of correlations between the scales included in the SF-POMS and the other 
measures examined. As hypothesized, of the POMS subscales, the CES-D is most highly 
correlated with the POMS subscale for depression (0.63). It is equally correlated (0.63) with the 
POMS Total Mood Disturbance scale, which is calculated by adding the scores on the five 
negative mood scales and subtracting the one positive mood scale (Vigor) from this sum. The 
other subscales also correlated over 0.40, except for the POMS subscale for fatigue, which is at 
the 0.34 level. The BNAS shows a similar pattern, with its highest correlation with the POMS 
Total Mood Disturbance score (0.60) and its lowest correlation with the POMS-Vigor subscale 
(0.26). The Positive Affect Scale has its highest correlation with the POMS-Vigor subscale 
(0.53), and its correlations are negative with the negative subscales and the POMS-Total. As 
predicted, the MOS Physical Functioning scale has its highest correlations with the Fatigue and 
Vigor subscale scores. Similarly, the other measure of physical functioning, the Self-Rated 
Karnofsky, shows its highest correlations with the Fatigue and Vigor subscale scores. This 
pattern of correlations provides support for the convergent validity of the Shacham POMS-SF. 
The divergent validity of the Anger, Confusion, Depression, and Tension subscales is supported 
by the low correlations with the two measures of physical functioning, the MOS Physical 
Functioning Scale and the Self-Rated Karnofsky. 
Table 4 is omitted from this formatted document. 
DISCUSSION  
Shacham (1983) reported internal consistency estimates (Cronbach’s alpha) over 0.80 for all six 
subscales of the shortened form of the POMS. Curran et al. (1995) obtained alphas for the 
subscales for the six samples of sick and healthy adults they studied that ranged from 0.76 to 
0.95, with the lowest alphas obtained for sample scores on the POMS-Confusion subscale. The 
alphas for two of the subscales in our study were at least 0.90 (Vigor and Fatigue), and all were 
over 0.80 except for the POMS-Confusion subscale, which had a slightly lower alpha of 0.78. 
The internal consistencies of several of the subscales were higher than those for their longer 
versions in the original POMS. All the alphas obtained in the current study are well within the 
range recommended by Nunnally and Bernstein (1994) for group comparisons on a scale. 
Table 5. Means (S.D.) for SF POMS scales by depression* status 
POMS scale/CES-D caseness status  n  Scale Mean  S.D.  t statistic (df)**  P value 
POMS total mood disturbance 
Not depressed    265  13.14   15.05  _16.56 
Depressed     147  44.07   19.68  (242)    0.000 
POMS anger 
Not depressed    266  4.46   3.55  _10.92 
Depressed     147  10.05   5.63  (212)   0.000 
POMS confusion 
Not depressed    266  4.77   3.39  _10.58 
Depressed     147  8.94   4.05  (260)    0.000 
POMS depression 
Not depressed    267  4.39   3.17  _14.87 
Depressed     147  11.90   5.66  (198)   0.000 
POMS vigor 
Not depressed    267  14.37   4.77  8.81 
Depressed     147  9.98   4.99  (412)    0.000 
POMS fatigue 
Not depressed    266  5.63   4.18  _7.41 
Depressed     147  8.85   4.31  (411)    0.000 
POMS tension 
Not depressed    267  8.20   4.23  _12.54 
Depressed     147  14.30   4.99  (262)    0.000 
*Depression as defined by a CES-D score _16 
**Large variations in the numbers of degrees of freedom (d.f.) occur because the assumption of 
equal variances is not valid for some comparisons. 
Data supporting the convergent and discriminant validity of the shortened version of the six 
subscales and the Total Mood Disturbance score from the 37-item version of the POMS were 
also obtained. The six POMS subscales and the POMS Total Mood Disturbance were correlated 
with the CES-D, the MOS SF-20 Physical Functioning, the Self-Reported Karnofsky, and the 
Bradburn Positive and Negative Affect Scales. The convergent validity correlations between the 
POMS-Depression and the POMS Total Mood Disturbance scores and the CES-D were the 
highest at 0.63. The Negative Affect Scale showed positive correlations at 0.44 or over with the 
negative scales of the POMS, except for the POMS-Fatigue Scale, with which it had a 
correlation of only 0.34. The POMS-Fatigue scale was only correlated at the 0.34 level with the 
CES-D as well. These lower correlations may be related to the fact that fatigue is not a major 
issue for patients at the time they are awaiting bone marrow transplantation and is not strongly 
related to their degree of depressive symptomatology. The one positive mood subscale of the 
POMS, the Vigor subscale, had a correlation with the other positive measure, the Positive Affect 
Scale, of 0.53. The discriminant correlations of the Positive Affect Scale with all the negative 
mood scales were lower and negative, as one would expect. The low correlation of the 
Depression, Tension, Anger, and Confusion subscales with the two measures of physical 
functioning supported the divergent validity of the SF-POMS. 
Confirmatory factor analysis, which was not done with Shacham’s relatively small sample of 
cancer patients, produced results that support the six-factor interpretation of the POMS items in 
the Shacham POMS-SF. The fit of the six-factor (subscale) model to the data is adequate, and the 
factor loading of each item retained in the shorter scales was highly statistically significant. 
There are several aspects of the model fit that lend further support to our conclusion that the fit 
of the model is reasonable. First, in addition to the RMR being rather small, the residuals are 
normally distributed. Second, the error terms for the individual items are small and consistent 
across items. Third, the items are fairly well predicted, with R-squares ranging from 0.22 to 0.78. 
Fourth, the modification indices produced by AMOS indicate that only small improvements in 
the fit would result from allowing error terms among the items to covary. Fifth, the variance of 
items is fairly consistent across items. Finally, inspection of the correlation matrix indicates that 
correlation among items is in the moderate range (even poor models are relatively easy to fit with 
low correlations among items). 
High correlations between subscales may be a source of lack of fit in the model. However, 
McNair et al. (1992) have reported that correlations between Tension-Anxiety and the other 
mood scales tend to be higher in patient groups than ‘normal’ groups. As the purpose of this 
investigation was to test the retention of the original subscale structure in the Shacham POMS-
SF, we have not ‘tweaked’ the model in order to obtain a better fit. 
A limitation of this study should be noted. Since the sample of cancer patients studied were all 
BMT candidates, they are somewhat different from many of the groups of cancer patients studied 
in the literature. For the most part, they were younger and most had critically life-threatening 
hematologic disease. Accordingly, it will be useful to further examine the performance of the 
Shacham POMS-SF in other large samples of cancer patients who are older and more diverse in 
diagnosis and risk status.   
In summary, our data on the 37-item short-form of the POMS (POMS-SF) show that this version 
of the POMS maintains the factor-based sixsubscale structure of the original 65-item version of 
the POMS. It also maintains or surpasses the level of internal consistency of the subscales of the 
longer version of this instrument. Correlations with other measures of mood and physical 
functioning confirm the convergent and discriminant validity of the POMS-SF. Thus, the 
Shacham POMS-SF, which offers a considerably shorter administration time while retaining the 
six-subscale structure with cancer patients, provides an acceptable alternative to the original 65-
item and the ‘brief ’ 11-item versions. Given the need for outcome measures in the era of 
managed care, the Shacham POMS-SF can serve as a brief measure of distress following 
psychosocial interventions, or as one indicator of quality of life following the completion of a 
variety of cancer therapies. 
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